In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Forendo Pharma Ltd.

www.forendo.com

Latest From Forendo Pharma Ltd.

Vesalius’s “Proven Investment Strategy” Reflected In Largest Fund Close To Date

European fund manager Vesalius has closed its third fund with €120m. Its managers believe their strategy of investing in maturing companies has been the key to attracting commitments, including from the European Investment Fund.

Europe Financing

True Innovation In Women’s Health Hindered Because Conditions Are Not Fatal

Drug developers and financiers discuss the biggest challenges delaying novel R&D in diseases effecting only women and how poor awareness of the debilitating symptoms that come with some conditions has led to a lack of emphasis on innovative research.

Clinical Trials Innovation

Appointments: Roche, Eli Lilly, Ipsen And Syros Make New Leadership Hires, Plus Board Appointments At EUSA, Autolus And Forendo

The latest biopharma industry personnel moves include a new executive hires at Roche, Lilly Oncology, Ipsen and Syros, a resignation at Five Prime, plus new board appointments at EUSA, Autolus and Forendo. 

Appointments BioPharmaceutical

Appointments: Changes At Merck KGaA, Servier, Unum and Aduro

The latest biopharma industry appointments include a new chief patient officer at Servier, executives at Merck KGaA, Unum and Aduro, as well as several board updates.

Appointments BioPharmaceutical
See All

Company Information

  • Industry
  • Biotechnology
  • Pharmaceuticals
  • Therapeutic Areas
  • Gynecological, Urological
  • Metabolic Disorders
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • Europe
      • Western Europe
        • Scandinavia
          • Finland
  • Parent & Subsidiaries
  • Forendo Pharma Ltd.
  • Senior Management
  • Risto Lammintausta, CEO
  • Contact Info
  • Forendo Pharma Ltd.
    Phone: 40 310 8000
    Itäinen Pitkäkatu 4 B
    Turku, FI-20520
    Finland
Advertisement
Advertisement
UsernamePublicRestriction

Register